Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma

T. K. Choueiri, P. Tomczak, S. H. Park, B. Venugopal, T. Ferguson, Y. H. Chang, J. Hajek, S. N. Symeonides, J. L. Lee, N. Sarwar, A. Thiery-Vuillemin, M. Gross-Goupil, M. Mahave, N. B. Haas, P. Sawrycki, H. Gurney, C. Chevreau, B. Melichar, E. Kopyltsov, A. AlvaJ. M. Burke, G. Doshi, D. Topart, S. Oudard, H. Hammers, H. Kitamura, J. Bedke, R. F. Perini, P. Zhang, K. Imai, J. Willemann-Rogerio, D. I. Quinn, T. Powles

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences